RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 87 filers reported holding RELMADA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $327,930 | +24.8% | 109,310 | +45.2% | 0.00% | +50.0% |
| Q4 2022 | $262,797 | -95.3% | 75,300 | -50.0% | 0.00% | -95.7% |
| Q3 2022 | $5,572,000 | +351.2% | 150,500 | +174.6% | 0.05% | +327.3% |
| Q4 2021 | $1,235,000 | -58.3% | 54,800 | -51.5% | 0.01% | -64.5% |
| Q3 2021 | $2,961,000 | +60.2% | 112,938 | +95.5% | 0.03% | +55.0% |
| Q2 2021 | $1,848,000 | -3.6% | 57,761 | +6.0% | 0.02% | -13.0% |
| Q1 2021 | $1,918,000 | – | 54,501 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |